Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$0.36
+3.1%		$0.41
$0.35
▼
$1.22
$22M1.3955,207 shs88,332 shs
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$0.69
+7.7%		$0.77
$0.60
▼
$1.69
$26.15M1.2310,960 shs17,300 shs
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
$0.66
-1.5%		$0.69
$0.60
▼
$1.14
$19.76M1.2263,999 shs9,202 shs
SurgePays, Inc. stock logo
SURG
SurgePays
$0.22
+0.9%		$0.40
$0.21
▼
$3.22
$5.43M0.381.54 million shs963,486 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-1.10%-3.13%-6.39%-42.61%-61.95%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
+1.59%-4.48%-23.81%-18.00%-18.99%
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
-0.59%-1.47%-6.94%+6.08%-9.46%
SurgePays, Inc. stock logo
SURG
SurgePays
-8.09%-14.93%-40.17%-64.04%-92.06%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$0.36
+3.1%		$0.41
$0.35
▼
$1.22
$22M1.3955,207 shs88,332 shs
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$0.69
+7.7%		$0.77
$0.60
▼
$1.69
$26.15M1.2310,960 shs17,300 shs
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
$0.66
-1.5%		$0.69
$0.60
▼
$1.14
$19.76M1.2263,999 shs9,202 shs
SurgePays, Inc. stock logo
SURG
SurgePays
$0.22
+0.9%		$0.40
$0.21
▼
$3.22
$5.43M0.381.54 million shs963,486 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-1.10%-3.13%-6.39%-42.61%-61.95%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
+1.59%-4.48%-23.81%-18.00%-18.99%
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
-0.59%-1.47%-6.94%+6.08%-9.46%
SurgePays, Inc. stock logo
SURG
SurgePays
-8.09%-14.93%-40.17%-64.04%-92.06%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
2.00
Hold$5.381,389.33% Upside
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.00
N/AN/AN/A
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
0.00
N/AN/AN/A
SurgePays, Inc. stock logo
SURG
SurgePays
1.67
Reduce$3.501,505.50% Upside

Current Analyst Ratings Breakdown

Latest SURG, PETV, CTSO, and RVP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/6/2026
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/10/2026
SurgePays, Inc. stock logo
SURG
SurgePays
Ascendiant Capital Markets logo
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$5.00 ➝ $3.50
5/22/2026
SurgePays, Inc. stock logo
SURG
SurgePays
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
5/15/2026
SurgePays, Inc. stock logo
SURG
SurgePays
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
(Data available from 7/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$37.06M0.61N/AN/A$0.09 per share4.01
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$1.05M25.00N/AN/A($0.03) per share-22.97
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
$37.15M0.53$0.01 per share48.25$3.31 per share0.20
SurgePays, Inc. stock logo
SURG
SurgePays
$56.96M0.10N/AN/A($0.66) per share-0.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$8.20M-$0.19N/A12.03N/A-31.85%-235.57%-37.88%8/6/2026 (Estimated)
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
-$10.95M-$0.38N/AN/AN/A-902.82%-4,813.07%-281.78%8/13/2026 (Estimated)
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
-$7.01M-$0.21N/AN/AN/A-41.11%-17.15%-9.33%N/A
SurgePays, Inc. stock logo
SURG
SurgePays
-$36.07M-$1.94N/A4.36N/A-64.91%N/A-310.16%8/12/2026 (Estimated)

Latest SURG, PETV, CTSO, and RVP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026N/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
-$0.08N/AN/AN/A$0.01 millionN/A
8/12/2026Q2 2026
SurgePays, Inc. stock logo
SURG
SurgePays
-$0.11N/AN/AN/A$13.80 millionN/A
8/6/2026Q2 2026
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.05N/AN/AN/A$9.39 millionN/A
5/20/2026Q4 2025
SurgePays, Inc. stock logo
SURG
SurgePays
-$0.19-$0.51-$0.32-$0.51$15.50 million$15.98 million
5/13/2026Q1 2026
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.06-$0.08-$0.02-$0.08$9.40 million$8.86 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
N/AN/AN/AN/AN/A
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
N/AN/AN/AN/AN/A
SurgePays, Inc. stock logo
SURG
SurgePays
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
4.70
1.09
0.81
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.02
0.42
0.47
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
0.01
8.57
5.92
SurgePays, Inc. stock logo
SURG
SurgePays
N/A
0.27
0.26

Institutional Ownership

CompanyInstitutional Ownership
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
32.87%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
24.55%
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
7.58%
SurgePays, Inc. stock logo
SURG
SurgePays
6.94%

Insider Ownership

CompanyInsider Ownership
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
7.80%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
10.84%
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
59.50%
SurgePays, Inc. stock logo
SURG
SurgePays
29.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
22062.84 million57.94 millionOptionable
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
2037.95 million19.06 millionNot Optionable
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
24029.94 million13.47 millionOptionable
SurgePays, Inc. stock logo
SURG
SurgePays
4025.12 million17.81 millionOptionable

Recent News About These Companies

SurgePays, Inc. (SURG) Stock Rises on Q1 2026 Earnings
July 29 at 8:11 PM  |  quiverquant.comQ
SurgePays Reports $142,725 in June Sales from Low Weekly Payments Pilot, Explores Joint Venture Expansion
July 29 at 9:31 AM  |  quiverquant.comQ
SurgePays Smartphone Rent-to-Own Program Scales 95x in 60 Days
July 29 at 9:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/29/3335257/0/en/surgepays-smartphone-rent-to-own-program-scales-95x-in-60-days.html
SurgePays Announces Derron Winfrey to Speak at All Wireless & Prepaid Expo 2026, Debuts New LinkUp Mobile Dealer Compensation Model
July 16, 2026  |  quiverquant.comQ
SurgePays' Derron Winfrey to Speak at All Wireless & Prepaid Expo 2026
July 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/16/3328564/0/en/surgepays-derron-winfrey-to-speak-at-all-wireless-prepaid-expo-2026.html
SurgePays, Inc. (SURG) Stock Major Holders - Yahoo Finance
July 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/SURG/holders/
SurgePays stock skyrockets 35% after eliminating $50 million AT&T spend rule
July 2, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/surgepays-stock-skyrockets-35-after-eliminating-50-million-at-t-spend-rule/ar-AA27606d
Why SurgePays Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket
July 2, 2026  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/26/07/60238330/why-surgepays-shares-are-trading-higher-by-59-here-are-20-stocks-moving-premarket?utm_source=snapi
SurgePays Restructures Wholesale Carrier Agreement to Support Profitable Wireless Subscriber Growth
July 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/01/3321011/0/en/surgepays-restructures-wholesale-carrier-agreement-to-support-profitable-wireless-subscriber-growth.html
SurgePays Shareholders Approve Directors and Capital Structure Changes
June 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/surgepays-shareholders-approve-directors-and-capital-structure-changes?utm_source=marketbeat.com&utm_medium=referral
SurgePays Secures New Convertible Note Financing Deal
June 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/surgepays-secures-new-convertible-note-financing-deal?utm_source=marketbeat.com&utm_medium=referral
Insider Buying: SurgePays (NASDAQ:SURG) Director Acquires 34,716 Shares of Stock
June 6, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-surg-insider-buying-and-selling-2026-06-06/
SurgePays Engages BrandRap to Develop AI Decisioning Engine for ProgramBenefits.com to Enhance Subscriber Revenue
June 5, 2026  |  quiverquant.comQ
SurgePays Signs Master Services Agreement with BrandRap to Build Artificial Intelligence (AI) Decisioning Engine to Drive Higher Revenue Per Subscriber
June 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/05/3307439/0/en/surgepays-signs-master-services-agreement-with-brandrap-to-build-artificial-intelligence-ai-decisioning-engine-to-drive-higher-revenue-per-subscriber.html
Why The Narrative Around SurgePays (SURG) Is Shifting After New Risk And Valuation Updates
June 1, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/why-narrative-around-surgepays-surg-061331637.html
Surgepays Inc (SURG) Q1 2026 Earnings Call Highlights: Robust Revenue Growth Amid Operational ...
May 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/surgepays-inc-surg-q1-2026-230021650.html
SurgePays Delays Quarterly Report Filing Briefly
May 15, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/surgepays-delays-quarterly-report-filing-briefly?utm_source=marketbeat.com&utm_medium=referral
SurgePays Reports First Quarter 2026 Revenue of Approximately $16 Million, Up 51% Year-Over-Year Driven by Point of Sale and Prepaid Services Growth of 71%
May 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/15/3295883/0/en/surgepays-reports-first-quarter-2026-revenue-of-approximately-16-million-up-51-year-over-year-driven-by-point-of-sale-and-prepaid-services-growth-of-71.html
SurgePays, Inc. Launches 25,000 Activation Pilot to Monetize Subprime Customer Base Through Alpha Cash Integration
May 12, 2026  |  quiverquant.comQ
SurgePays Launches Alpha Cash Pilot to Monetize Subprime Consumer Distribution, First in a Planned Series
May 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/12/3292843/0/en/surgepays-launches-alpha-cash-pilot-to-monetize-subprime-consumer-distribution-first-in-a-planned-series.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AST SpaceMobile promotional graphic showing a satellite orbiting Earth with the company logo overlaid.
AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
By Jessica Mitacek | July 3, 2026
A semi-truck hauls a large cylindrical industrial component past police cars on a nighttime industrial roadway.
These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
By Nathan Reiff | July 28, 2026
Voltmax electrical equipment and cable spools at an industrial construction site with a steel-framed building under construction.
3 Non-Tech Stocks Still Winning Big on AI
By Nathan Reiff | July 13, 2026
Tesla electric vehicle with red Tesla logo and branding, reflecting valuation pullback narrative
Tesla Stock Surges 15% as FSD Update Backs Its Autonomy Thesis
By Sam Quirke | July 2, 2026
Regal Rexnord logo displayed alongside industrial motors, gears, bearings, and drive components.
This Under-the-Radar Industrial Is Quietly Powering AI
By Peter Frank | July 5, 2026
Cytosorbents stock logo

Cytosorbents NASDAQ:CTSO

$0.36 +0.01 (+3.08%)
Closing price 04:00 PM Eastern
Extended Trading
$0.36 0.00 (-0.25%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

PetVivo stock logo

PetVivo NASDAQ:PETV

$0.69 +0.05 (+7.66%)
As of 03:57 PM Eastern

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Retractable Technologies stock logo

Retractable Technologies NYSE:RVP

$0.66 -0.01 (-1.46%)
Closing price 04:00 PM Eastern
Extended Trading
$0.67 +0.01 (+1.79%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

SurgePays stock logo

SurgePays NASDAQ:SURG

$0.22 +0.00 (+0.93%)
Closing price 04:00 PM Eastern
Extended Trading
$0.21 -0.01 (-3.67%)
As of 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas